nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
|
|
|
2005 |
|
13 |
p. 155-171 |
artikel |
2 |
Antioxidants and endothelial nitric oxide synthesis
|
Heller, Regine |
|
2005 |
|
13 |
p. 21-28 |
artikel |
3 |
Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease: the multicenter CARDIAC study
|
Lenzen, Henrike |
|
2005 |
|
13 |
p. 45-49 |
artikel |
4 |
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of angiogenesis
|
Cooke, John P. |
|
2005 |
|
13 |
p. 115-121 |
artikel |
5 |
Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD)
|
Zoccali, Carmine |
|
2005 |
|
13 |
p. 131-135 |
artikel |
6 |
Author index (A = Abstract; R = Review)
|
|
|
2005 |
|
13 |
p. 173-174 |
artikel |
7 |
Cardiac allograft endothelial dysfunction
|
Kofler, Sieglinde |
|
2005 |
|
13 |
p. 79-82 |
artikel |
8 |
Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis
|
Tsikas, Dimitrios |
|
2005 |
|
13 |
p. 51-59 |
artikel |
9 |
Effect of L-arginine supplementation on NO production in man
|
Bode-Böger, Stefanie M. |
|
2005 |
|
13 |
p. 91-99 |
artikel |
10 |
Effects of asymmetric dimethylarginine (ADMA) infusion in humans
|
Kielstein, Jan T. |
|
2005 |
|
13 |
p. 39-44 |
artikel |
11 |
Endothelial NO synthase as a source of NO and superoxide
|
Förstermann, Ulrich |
|
2005 |
|
13 |
p. 5-12 |
artikel |
12 |
Festschrift Professor Jürgen C. Frölich
|
Roots, Ivar |
|
2006 |
|
13 |
p. 1-2 |
artikel |
13 |
Growth hormone regulates vascular function—what we know from bench and bedside
|
Thum, Thomas |
|
2005 |
|
13 |
p. 29-32 |
artikel |
14 |
Growth hormone, vascular reactivity, and heart failure
|
Napoli, Raffaele |
|
2005 |
|
13 |
p. 141-144 |
artikel |
15 |
Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chromatography-mass spectrometry quantification
|
Martens-Lobenhoffer, Jens |
|
2005 |
|
13 |
p. 61-68 |
artikel |
16 |
Nitric oxide and endothelial cell aging
|
Haendeler, Judith |
|
2005 |
|
13 |
p. 137-140 |
artikel |
17 |
Nitric oxide deficiency in chronic renal disease
|
Baylis, Chris |
|
2005 |
|
13 |
p. 123-130 |
artikel |
18 |
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives
|
Bolla, Manlio |
|
2005 |
|
13 |
p. 145-154 |
artikel |
19 |
Nitric oxide in coronary artery disease: effects of antioxidants
|
Tousoulis, Dimitris |
|
2005 |
|
13 |
p. 101-107 |
artikel |
20 |
Nitric oxide synthase gene transfer and treatment of restenosis: from bench to bedside
|
Leyen, Heiko E. von der |
|
2005 |
|
13 |
p. 83-89 |
artikel |
21 |
Oxidant stress—a major cause of reduced endothelial nitric oxide availability in cardiovascular disease
|
Landmesser, Ulf |
|
2005 |
|
13 |
p. 13-19 |
artikel |
22 |
Relation between β-adrenoceptor stimulation and nitric oxide synthesis in vascular control
|
Ritter, James M. |
|
2005 |
|
13 |
p. 109-113 |
artikel |
23 |
The role of nitric oxide in early atherosclerosis
|
Charakida, Marietta |
|
2005 |
|
13 |
p. 69-78 |
artikel |
24 |
The synthesis and metabolism of asymmetric dimethylarginine (ADMA)
|
Leiper, James M. |
|
2005 |
|
13 |
p. 33-38 |
artikel |
25 |
Vascular NO: from bench to bedside
|
Tsikas, Dimitrios |
|
2005 |
|
13 |
p. 3 |
artikel |